CR
Insider
Chad M Robins
CEO and ChairmanChad M Robins (CEO and Chairman) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $14.8M of ADPT (597,271 sh across 2 lots, as filed), executed Aug 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$39.6M
shares × price, as filed
Last traded
Aug 18
Filed Aug 19
Median ADV $72.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $47.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
ADPTRecent filings
ADPTSALE
Adaptive Biotechnologies Corporation
View filing →
$14.8M597,271 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 8:15 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.8M
120,595 sh across 2 lots
Exec Apr 6
Filed Apr 8 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $6.2M
470,167 sh across 2 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $8.3M
522,618 sh across 3 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $2.3M
124,998 sh × $18.44
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.9M
124,998 sh × $15.59
Exec Jan 5
Filed Jan 7 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $3.1M
160,734 sh across 2 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.3M
86,161 sh × $14.73
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET More filings →